Jiangsu Hengrui Me. traded at 38.80 this Friday July 1st, increasing 1.71 or 4.61 percent since the previous trading session. Looking back, over the last four weeks, Jiangsu Hengrui Me. gained 30.03 percent. Over the last 12 months, its price fell by 42.01 percent. Looking ahead, we forecast Jiangsu Hengrui Me. to be priced at 32.56 by the end of this quarter and at 29.83 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
38.80
Daily Change
4.61%
Yearly
-42.01%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Cspc Pharmaceutical 7.79 0.16 2.10% -29.44%
Sino Biopharmaceutical Ltd 4.97 0.28 5.97% -33.47%
Sh Fosun Pharma 45.99 1.90 4.31% -36.13%
Sh Pharmaceutical 17.99 -0.09 -0.50% -13.43%
WuXi AppTec Co Ltd 102.60 -1.39 -1.34% -33.83%

Indexes Price Day Year
SHANGHAI 3388 -10.98 -0.32% -3.73%
SHANGHAI 50 3045 -13.13 -0.43% -10.65%

Jiangsu Hengrui Me.
Jiangsu Hengrui Pharmaceuticals Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical tablets, injections and raw materials. The Company's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty infusions and others. The Company distributes its products within domestic market and to overseas markets.